🚨🚨 Billionaire cancer doctor Patrick Soon-Shiong told Tucker Carlson that nearly every oncologist ignores the one number in your blood test that kills cancer: “Pick up the phone, call any random oncologist—not to shame them—and say: ‘You do a blood count, right?’ A complete blood count. You take blood and check if you’re anemic or not.” “And you give chemotherapy and radiation, and you ask: ‘What are you looking for?’ Well, we look to see if you’re anemic, so we can give you this drug made by Amgen called Epogen. We look to see if your platelets have dropped, so we can give you a platelet transfusion. We look to see if your neutrophils have dropped so you don’t get an infection, so we give you Neupogen.” “Well, the problem is, do red blood cells kill cancer? No. Do platelets kill cancer? No. Do neutrophils kill cancer? No.” “What kills cancer? Natural killer cells and T cells. So in that blood count, there’s one thing called lymphocytes. Do you look at that? No.” “The only cell that’s important, that kills cancer, and 99.9% of oncologists will say: ‘We don’t pay any attention to that.’” Even Tucker couldn’t believe it: “Why, if you’re fighting cancer, would you ignore the one cell that fights cancer?” “That’s the missing link. That’s the key element in your body.”

A medical substance most people have never heard of is quietly being used for autoimmune disease, nerve injury, and conditions doctors call “untreatable.” Dr. James Miller, a retired trauma surgeon, says DMSO works so well for so many things that it “seems unbelievable.” In this clip he explains why: It changes the polarity of cells so they stop clumping and start signaling again. That, he says, is why the same compound shows up in stories of recovery from chronic nerve inflammation, diabetic neuropathy, arthritis, stroke disability, chronic pain, and even cancer. His framing: it’s extremely safe — “like salt.” Hard to hurt someone with it, easy to overlook. If you’ve never heard of DMSO, that’s not an accident. It has been studied for decades, used internationally, and even folded into some FDA-approved therapies. In mainstream U.S. medicine, it’s mostly missing.

🚨 Dr. William Makis just dropped his updated Ivermectin & Fenbendazole Cancer Protocol. And people are losing their minds. Not because it's controversial. Because it gives real answers. Here's the truth: Most protocols treat every cancer the same. Dr. Makis says that's a mistake. A patient in remission ≠ a patient with widespread metastases. A slow-growing tumor ≠ aggressive brain cancer. So he designed FOUR dosing levels. Not one. Four. 👇 🟢 LOW DOSE Ivermectin: ≤ 0.5 mg/kg – 3x per week Fenbendazole: 222 mg/day – 3 days on, 4 off Best for: Remission support, prevention, strong family history, higher risk individuals. 🟡 MEDIUM DOSE Ivermectin: 1.0 mg/kg – daily Fenbendazole: 222 mg/day – 6 days per week Best for: Most active cancers – common starting approach. 🔵 HIGH DOSE Ivermectin: 2.0 mg/kg – daily Fenbendazole: 444 mg/day – 6 days per week Best for: Aggressive cancers, brain cancer, leukemia, pancreatic cancer. 🔴 VERY HIGH DOSE Ivermectin: ≥ 2.5 mg/kg – daily Fenbendazole: 888-1000 mg/day – 6 days per week Best for: Extensive metastatic disease, poor prognosis cases. 💡 Why is this different? It's not about the numbers. It's about the thinking behind them. Dr. Makis believes cancer isn't one disease. It's many. And a one-size-fits-all approach? That doesn't always make sense. 🔬 The research is growing. Ivermectin and Fenbendazole are being studied for how they interact with: • Cancer metabolism • Cancer stem cells • Mitochondrial function • Tumor signaling pathways • Treatment resistance mechanisms • Cellular energy production One thing is undeniable: More cancer patients, caregivers, and researchers are talking about repurposed medicines today than ever before. And that's exactly why charts like this keep getting shared. 📌 Save this chart. Six months from now, you'll wish you knew where to find it. 🔁 Repost it. Someone researching cancer protocols needs to see this.